JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, cilt.76, sa.8, ss.1653-1659, 2018 (SCI-Expanded)
Purpose: Recombinant human hyaluronidase (rHuPH20) is widely used as a spreading factor, which enhances the absorption of subcutaneously injected medicines. The anti-inflammatory and anti-edema effects of the enzyme were demonstrated in previous studies. In the present study, the anti-edema effect of rHuPH20 was compared with that of dexamethasone in a traumatic rat paw edema model.